NCT05430412 - CT to Assess the Efficacy and Safety of Adding GMA to Infliximab in Paediatric Patients With Steroid-refractory Ulcerative Colitis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 11, 2022

Primary Completion Date

October 31, 2024

Study Completion Date

October 31, 2024

Conditions

Ulcerative Colitis

Interventions

DEVICE

Adacolumn

The study will consist of 10 sessions of Adacolumn® treatment (once per week) and a follow-up period (from week 12 to week 40 since study inclusion).

Trial Locations (10)

RECRUITING

Hospital Coimbra, Coimbra

RECRUITING

Hospital Santa Maria, Lisbon

RECRUITING

Hospital Soa Joao, Porto

RECRUITING

Hospital H. Sant Joan de Déu, Sant Joan Despí

RECRUITING

Hospital Universitari Vall d'Hebron, Barcelona

RECRUITING

Hospital Infantil Universitario Niño Jesús, Madrid

RECRUITING

Hospital Materno-Infantil del H.U.R. de Málaga, Málaga

RECRUITING

Hospital U. Ntra Señora de Candelaria, Santa Cruz de Tenerife

RECRUITING

Complejo H. Regional Virgen Del Rocío, Seville

RECRUITING

Hospital Universitari I Politècnic La Fe, Valencia